Manidipine–delapril combination in the management of hypertension

References

• BanegasJRSeguraJRuilopeLMBlood pressure control and physician management of hypertension in hospital hypertension units in SpainHypertension20044313384415117908
   PubMed Web of Science ®Google Scholar
• BachelliSDegli EspositiDAlbericiMEffects of the combination of different doses of manidipine and delapril in hypertesive patientsAm J Hypertens200215456A
   Google Scholar
• BerlowitzDRAshASHickeyECInadequate management of blood pressure in a hypertensive populationN Engl J Med19983391957639869666
   PubMed Web of Science ®Google Scholar
• [BPLTT] Blood Pressure Lowering Treatment Trialists’ CollaborationEffects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed. overviews of randomised trialsLancet200336215273514615107
   PubMed Web of Science ®Google Scholar
• [BPLTT] Blood Pressure Lowering Treatment Trialists’ CollaborationEffects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trialsArch Intern Med200516514101915983291
   PubMedGoogle Scholar
• ChobanianAVBakrisGBlackHThe Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 ReportJAMA200328925607212748199
   PubMed Web of Science ®Google Scholar
• DahlöfBSeverPSPoulterNRPrevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trialLancet200536689590616154016
   PubMed Web of Science ®Google Scholar
• De LeeuwPWKroonAAFixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertensionJ Hypertens199715Suppl 23942
   Google Scholar
• FogariRZoppiALusardiPEvaluation by 24-hour ambulatory blood pressure monitoring of efficacy of manidipine hydrochloride 10, 20 or 40 mg once daily ascompared to placebo in treating mild to moderate essential hypertension: a double-blind, randomized, parallel group, placebo-controlled studyBlood Press19965Suppl 516238777468
   PubMedGoogle Scholar
• FogariRZoppiAMugelliniAEfficacy of delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoringAdv Ther19971425461
   Web of Science ®Google Scholar
• FogariRZoppiACorradiLEffects of different dihydropiridine calcium antagonists on plasma norepinephrine in essential hypertensionJ Hypertens2000181871511132613
   PubMed Web of Science ®Google Scholar
• FogariRMalamaniGDerosaGEffect of delapril addition to manidipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients [abstract no P-205]Am J Hypertens200316113A
   Web of Science ®Google Scholar
• FogariRAnkle edema and sympathetic activationDrugs200565Suppl 221716398059
   PubMedGoogle Scholar
• FogariRMugelliniAZoppiAEffect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuriaEur J Clin Pharmacol2005614839016021438
   PubMed Web of Science ®Google Scholar
• FurukawaTNukadaTMiuraRDifferential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytesJ Cardiovasc Pharmacol200545241615725949
   PubMed Web of Science ®Google Scholar
• GriffinKAPickenMMBidaniAKDeleterious effects of calcium channel blockers on pressures transmissions and glomerular injury in rat remmant kidneysJ Clin Invest1995967938007635974
   PubMed Web of Science ®Google Scholar
• Guidelines CommitteeEuropean Society of Hypertension–European Society of Cardiology Guidelines for the Management of Arterial HypertensionJ Hypertens20032110115312777938
   PubMed Web of Science ®Google Scholar
• HanssonLZanchettiACarruthersSGEffects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialLancet19983511755629635947
   PubMed Web of Science ®Google Scholar
• HayasiKNagahamaTOkaKDisparate effects of calcium antagonists on renal microcirculationHypertens Res1996193168829821
   PubMedGoogle Scholar
• IimuraOShimamotoKMasudaAEffects of a calcium channel blocker, manidipine, on insulin sensitivity in essential hypertensivesJ Diab Camp1995921519
   PubMed Web of Science ®Google Scholar
• JafarTHSchmidCHLandaMAngiotensin converting enzyme inhibitors and progression of nondiabetic renal diseaseAnn Intern Med200113573387
   Web of Science ®Google Scholar
• JuliusSKjeldsenSEWeberMOutcomes in hypertensive patients at high cardiovascular risk treated with valsartan- or amlodipine-based regimens: VALUE, a randomised trialLancet200436320223115207952
   PubMed Web of Science ®Google Scholar
• KarpatiPAlbericiMTocciGLong-term tolerability and efficacy of the fixed combination of manidipine and delapril in patients with essential hypertensionHigh Blood Press Cardiovasc Prev20031016
   Google Scholar
• KlingbeilAUSchneiderMMartusPA meta-analysis of the effect of treatment of left ventricular mass in essential hypertensionAm J Med200311541612867233
   PubMed Web of Science ®Google Scholar
• KlokeHJBrantenAJHuysmansFTAntihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?Kidney Int1998531559739607186
   PubMed Web of Science ®Google Scholar
• LawMRWaldNJMorrisJKValue of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trialsBMJ20033261407812829526
   PubMed Web of Science ®Google Scholar
• LetellierPOverlackAAgnesEPerindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with PerindoprilJ Hum Hypertens1994814598207741
   PubMed Web of Science ®Google Scholar
• LewisEJHunsickerLGBainRPThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study GroupN Engl J Med19933291456628413456
   PubMed Web of Science ®Google Scholar
• LondonGMPannierBVicautEAntihypertensive effects and arterial hemodynamic alterations during angiotensin converting enzyme inhibitionJ Hypertens1996141139468986916
   PubMed Web of Science ®Google Scholar
• LopezAMathersCDEzzatiMGlobal and regional burden of disease and risk factors, 2001: systematic analysis of population health dataLancet200636717475716731270
   PubMed Web of Science ®Google Scholar
• LiuLWangJGGongLComparison of active treatment and placebo for older Chinese patients with isolated systolic hypertensionJ Hypertens199816182399869017
   PubMed Web of Science ®Google Scholar
• Luque OteroMFernández PinillaCCatalánPAcute antihypertensives effect of nifedipine on high and low salt dietJ Cardiovasc Pharmacol198710Suppl 10S14782455119
   PubMedGoogle Scholar
• Luque OteroMMartell ClarosNon behalf of the Study Investigators GroupManidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week studyClin Ther2005271667315811479
   PubMed Web of Science ®Google Scholar
• ManciaGOmboniSAgabiti-RoseiEAntihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patientsJ Cardiovasc Pharmacol2000359263110836728
   PubMed Web of Science ®Google Scholar
• ManciaGGrassiGSystolic and diastolic blood pressure control in antihypertensive trialsJ Hypertens2002201461412172300
   PubMed Web of Science ®Google Scholar
• ManciaGVolpeRBorosSCardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist careJ Hypertens20042251715106794
   PubMed Web of Science ®Google Scholar
• ManciaGGrassiGZanchettiANew-onset diabetes and antihypertensive drugsJ Hypertens20062431016331092
   PubMed Web of Science ®Google Scholar
• Martinez-MartinFJSaiz-SatjesMAddition of manidipine in type 2 diabetic patients with uncontrolled hypertension and microalbuminuriaJ Hypertens200422Suppl 2s245
   PubMedGoogle Scholar
• McKeageKScottLJManidipine: a review of its use in the management of hypertensionDrugs20046419234015329044
   PubMed Web of Science ®Google Scholar
• MugelliniADobovisekJPlanincDEfficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trialClin Ther20042614192615531004
   PubMed Web of Science ®Google Scholar
• MugelliniAPretiPZoppiAEffect of delapril -manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitusJ Hum Hypertens2004186879115071488
   PubMed Web of Science ®Google Scholar
• MugelliniAVaccarellaACelentanoAFixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoringBlood Pressure200514Suppl 161316029993
   PubMedGoogle Scholar
• OkabeKTeradaKKitamuraKSelective and long lasting inhibitory actions of the dihydropyridine derivative, CV-4093, on calcium currents in smooth muscle cells of the rabbit pulmonary arteryJ Pharmacol Exp Ther1987243703103681701
   PubMed Web of Science ®Google Scholar
• OnoyamaKNanishiFOkudaSPharmacokinetics of a new angiotensin I converting enzyme inhibitor (delapril) in patients with deteriorated kidney function and in normal control subjectsClin Pharmacol Ther19884324293345615
   PubMed Web of Science ®Google Scholar
• PittBDiversity of calcium antagonistsClin Ther199719Suppl A3179385501
   PubMedGoogle Scholar
• Prospective Studies CollaborationAge-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesLancet2002360190312493255
   PubMed Web of Science ®Google Scholar
• RizzoniDBevilacquaMGobbatoCBlood pressure lowering effects of delapril and manidipine, in hypertensive patients with type 2 diabetes, not adequately controlled by monotherapy [abstract]High Blood Press Cardiovasc Prev200512180 (abstract no. 8.6)
   Google Scholar
• RuggenentiPFassiAIlievaAPfor the Bergamo Nephrologic DIabetes Complications Trial (BENEDICT) Investigatorspreventing microalbuminuria in type 2 diabetesN Engl J Med200435119415115516697
   PubMed Web of Science ®Google Scholar
• SarutaTNishikawaKCharacteristics of a new angiotensin converting enzyme inhibitor: delaprilAm J Hypertens1991423S28S2009144
   PubMed Web of Science ®Google Scholar
• SchiffrinELDengLYLarochellePEffects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertensionHypertension19942383918282334
   PubMed Web of Science ®Google Scholar
• SharmaAWittchenH-UKirchWfor the HYDRA Study GroupHigh prevalence and poor control of hypertension in primary care: cross-sectional studyJ Hypertens2004224798615076152
   PubMed Web of Science ®Google Scholar
• SimonAGariepyJChironiGIntima-media thickness: a new tool for diagnosis and treatment of cardiovascular riskJ Hypertens2002201597011821696
   PubMed Web of Science ®Google Scholar
• StockisAGenglerCGoethalsFSingle oral dose pharmacokinetic interaction study of manidipine and delapril in healthy volunteersArzneimittelforschung2003536273414558436
   PubMed Web of Science ®Google Scholar
• SuzukiSOhtomoMSsatohYEffect of manidipine and delapril on insulin sensitivity in type 2diabetic patients with essential hypertensionDiab Res Clin Pract1996334351
   PubMed Web of Science ®Google Scholar
• SwalesPWiliamsBCalcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertensionJ Renin Aldosterone Syst200237989
   PubMed Web of Science ®Google Scholar
• TaddeiSVirdisAGhiadoniLRestoration of nitric oxide avaibility after calcium antagonist treatment in essential hypertensionHypertension200137943811244022
   PubMed Web of Science ®Google Scholar
• The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research GroupMajor outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)JAMA200228829819712479763
   PubMed Web of Science ®Google Scholar
• TojoAKimuraKMatsuokaHEffects of manidipine hydrochloride on the renal microcirculation in spontaneously hypertensive ratsJ Cardiovasc Pharmacol19922089591282591
   PubMed Web of Science ®Google Scholar
• TrimacoBArcucciOGacionigGEvaluation of different combination of antihypertensive drugs in hypertensive patients not adequately controlled by previous monotherapy [abstract]High Blood Press Cardiovasc200512180 (abstract no. 8.5)
   Google Scholar
• [VAC] Veterans Administration Cooperative Study Group on Antihypertensive AgentsEffects of treatment on morbidity in hypertension: II results in patients with diastolic blood pressure average 90 through 114 mm HgJAMA1970213114394914579
   PubMed Web of Science ®Google Scholar
• WatanabeHBlock of T-type calcium channel by dihydropyridine calcium antagonistsTeikyo Medical Journal20032642533
   Google Scholar
• Wolf-MaierKCooperRSBanegasJRHypertension prevalence and blood pressure levels in 6 European countries, Canada and the United StatesJAMA20032892363912746359
   PubMed Web of Science ®Google Scholar
• ZanchettiAOmboniSLa CommarrePEfficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertensionJ Cardiovasc Pharmacol2001386425011588535
   PubMed Web of Science ®Google Scholar
• ZanchettiARoseiEADal PaluCThe Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thicknessJ Hypertens1998161667769856368
   PubMed Web of Science ®Google Scholar
• ZanchettiABondMGHennigMEuropean Lacidipine Study on Atherosclerosis investigators Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trialCirculation20021062422712417537
   PubMed Web of Science ®Google Scholar
• ZanchiABrunnerHRWaeberBRenal hemodynamic and protective effects of calcium antagonist in hypertensionJ Hypertens1995131363758866898
   PubMedGoogle Scholar
• ZannadFMulticentre, randomised, parallel group, double-blind, phase III study to compare the antihypertensive effects and tolerability of delapril and manidipine monotherapy to delapril plus manidipine (CHF 1521 fixed combination) in patients with mild to moderate essential hypertension (Data on file). Chiesi Farmaceutici A.p.A2004
   Google Scholar
• ZoppiAMugelliniAPretiPEffects of the fixed combination of manidipine plus delapril in the treatment of hypertension inadequately controlled by monotherapy with either component: a phase III, multicenter, open-label, clinical trialCurr Ther Res20036442233
   PubMed Web of Science ®Google Scholar